VNRX Earnings

Quarterly EPS
$-1.40
Q3 2024
$-1.24
Q4 2024
$-1.12
Q1 2025
$-1.22
Q2 2025
$-1.00
Q3 2025
$-0.59
Q4 2025
$-0.97
Q1 2026
$-0.85
Q2 2026
Latest Revenue398.7K
Latest Net Income-7315263
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.85398.7K-7315263-2.0%+30.3%
Q1 2026-$0.97985.1K-6703557+299.8%+13.4%
Q4 2025-$0.59447.0K-6302841+133.2%+52.4%
Q3 2025-$1.00627.3K-5409791+32.2%+28.6%
Q2 2025-$1.22406.7K-6314070+2.8%+23.8%
Q1 2025-$1.12246.4K-5476627+43.6%+44.0%
Q4 2024-$1.24191.7K-5857227-21.4%+43.1%
Q3 2024-$1.40474.5K-5868578+187.2%+36.4%
Q2 2024-$1.60395.8K-7060175
Q1 2024-$2.00171.5K-8472005
Q4 2023-$2.18244.0K-8799700
Q3 2023-$2.20165.2K-8453188
VolitionRx (VNRX) — Earnings